
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial
Mine Durusu Tanrıöver, Özlem Altuntaş Aydın, Rahmet Güner, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1865-1865
Open Access | Times Cited: 16
Mine Durusu Tanrıöver, Özlem Altuntaş Aydın, Rahmet Güner, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1865-1865
Open Access | Times Cited: 16
Showing 16 citing articles:
COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic
Aleksandra Anna Zasada, Aniela Darlińska, Aldona Wiatrzyk, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1786-1786
Open Access | Times Cited: 23
Aleksandra Anna Zasada, Aniela Darlińska, Aldona Wiatrzyk, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1786-1786
Open Access | Times Cited: 23
COVID-19 Vaccines: Where Did We Stand at the End of 2023?
Kenneth Lundström
Viruses (2024) Vol. 16, Iss. 2, pp. 203-203
Open Access | Times Cited: 10
Kenneth Lundström
Viruses (2024) Vol. 16, Iss. 2, pp. 203-203
Open Access | Times Cited: 10
Transformative Approaches in SARS-CoV-2 Management: Vaccines, Therapeutics and Future Direction
Ankita Saha, Shweta Choudhary, Priyanshu Walia, et al.
Virology (2025) Vol. 604, pp. 110394-110394
Closed Access | Times Cited: 1
Ankita Saha, Shweta Choudhary, Priyanshu Walia, et al.
Virology (2025) Vol. 604, pp. 110394-110394
Closed Access | Times Cited: 1
Effect of homologous or heterologous vaccine booster over two initial doses of inactivated COVID-19 vaccine
Viravarn Luvira, Punnee Pitisuttithum
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 283-293
Open Access | Times Cited: 4
Viravarn Luvira, Punnee Pitisuttithum
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 283-293
Open Access | Times Cited: 4
COVID-19 vaccines: A comprehensive review of safety and efficacy
Zhipeng Yan, Ming Yang, Ching‐Lung Lai
Elsevier eBooks (2025), pp. 685-777
Closed Access
Zhipeng Yan, Ming Yang, Ching‐Lung Lai
Elsevier eBooks (2025), pp. 685-777
Closed Access
Immunobiology and immunotherapy of COVID-19
Kenneth Lundström
Progress in molecular biology and translational science (2025)
Closed Access
Kenneth Lundström
Progress in molecular biology and translational science (2025)
Closed Access
Efficacy of Inactivated Bivalent SARS-CoV-2 Vaccines Targeting Ancestral Strain (ERAGEM), Delta, and Omicron Variants
B. S. Kaplan, Shaikh Terkıs Islam Pavel, Muhammet Ali Uygut, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 169-169
Open Access
B. S. Kaplan, Shaikh Terkıs Islam Pavel, Muhammet Ali Uygut, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 169-169
Open Access
COVID-19 Vaccines: Where Do We Stand at the End of 2023?
Kenneth Lundström
(2024)
Open Access | Times Cited: 3
Kenneth Lundström
(2024)
Open Access | Times Cited: 3
Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up
Zafer Sezer, Shaikh Terkıs Islam Pavel, Ahmet İnal, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 140-140
Open Access | Times Cited: 2
Zafer Sezer, Shaikh Terkıs Islam Pavel, Ahmet İnal, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 140-140
Open Access | Times Cited: 2
Intensive Care during the COVID-19 Pandemic
Ying Wang, Yuefei Jin, Haiyan Yang
Vaccines (2023) Vol. 11, Iss. 1, pp. 125-125
Open Access | Times Cited: 2
Ying Wang, Yuefei Jin, Haiyan Yang
Vaccines (2023) Vol. 11, Iss. 1, pp. 125-125
Open Access | Times Cited: 2
Self-Reported Allergic Adverse Events Following Inactivated SARS-CoV-2 Vaccine (TURKOVAC™) among General and High-Risk Population
Ateş Kara, Aslihan Coskun, Fehminaz Temel, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 437-437
Open Access | Times Cited: 2
Ateş Kara, Aslihan Coskun, Fehminaz Temel, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 437-437
Open Access | Times Cited: 2
Assessing the robustness of COVID-19 vaccine efficacy trials: systematic review and meta-analysis, January 2023
Hoang Thi Ngoc Anh, Ha‐Linh Quach, Ngoc Van Hoang, et al.
Eurosurveillance (2023) Vol. 28, Iss. 22
Open Access | Times Cited: 2
Hoang Thi Ngoc Anh, Ha‐Linh Quach, Ngoc Van Hoang, et al.
Eurosurveillance (2023) Vol. 28, Iss. 22
Open Access | Times Cited: 2
The impact of previous SARS-CoV-2 infection on post-vaccine adverse events in individuals vaccinated with TURKOVAC or CoronaVac –inactivated COVID-19 vaccines
Mine Durusu Tanrıöver, Özlem Altuntaş Aydın, Rahmet Güner, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Mine Durusu Tanrıöver, Özlem Altuntaş Aydın, Rahmet Güner, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
An Outline of the Immunogenic Potential of Progressing SARSCoV- 2 Vaccine Technologies among Children and Adolescents
Hytham Ghanem, Shehab Ghanem, Ehsan Almutawa
Recent Patents on Biotechnology (2023) Vol. 18, Iss. 3, pp. 180-189
Closed Access
Hytham Ghanem, Shehab Ghanem, Ehsan Almutawa
Recent Patents on Biotechnology (2023) Vol. 18, Iss. 3, pp. 180-189
Closed Access
Prospective interpretation of Covid vaccines. A cross sectional study, Ordu province experience
Bestegül ÇORUH AKYOL, Bennur Turgut, Murat Doğan İşcanlı, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access
Bestegül ÇORUH AKYOL, Bennur Turgut, Murat Doğan İşcanlı, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access
Evaluation of covid-19 disease perception and attitudes towards vaccine of individuals who have had covid-19 vaccination in a tertiary hospital
Murat Karatürk, Nurcan Akbaş Güneş
The Journal of Turkish Family Physician (2023) Vol. 14, Iss. 3, pp. 150-163
Open Access
Murat Karatürk, Nurcan Akbaş Güneş
The Journal of Turkish Family Physician (2023) Vol. 14, Iss. 3, pp. 150-163
Open Access